Phacilitate Leaders Europe
|Date & Time||September 17-18, 2019|
Royal Lancaster London
This year, the agenda has been designed to address the 3 core challenges presented by the European advanced therapies marke:
- investment and innovation,
- manufacturing and commercialisation, and
- patient access and healthcare.
Bringing cell, gene and cellular IO into each of the tracks will facilitate the cross-pollination of these 3 modalities.In short, we aim to provide answers to the issues of the entire ecosystem of ATMPs, all the way from the conception of your cell and gene therapy, to introducing it to market and patient access.
Come and meet us in Person
David Morrow, EATRIS Scientific Programme Manager, and Chris Tieken, EATRIS Business Developer Manager, will attend this partnering event. We are looking forward to meeting you in London.